Argenx, a global immunology company dedicated to improving the lives of individuals with severe autoimmune diseases, has announced that it will host a conference call and audio webcast on Thursday, May 9, 2024, at 2:30 p.m. CET (8:30 a.m. ET) to discuss its financial results for the first quarter of 2024 and provide a business update.
To join the conference call, participants can use the following dial-in numbers: Belgium 32 800 50 201, France 33 800 943355, Netherlands 31 20 795 1090, United Kingdom 44 800 358 0970, United States